Latest research study from Market Research Future with title “Home Healthcare” by Manufacturers, Regions, Type and Application, Forecast to 2023. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, facts, historical data, and statistically supported and industry validated market data. The study is segmented by products type, application/end-users.
It is estimated that Home Healthcare Market is expected to grow at a CAGR of 8.1% during the forecast period 2017-2023. In the coming years, the global economy will witness a sharp increase in the home health industry. The increased competition among existing and new market players to develop a device with higher accuracy and more advanced features will ultimately results in the growth of the market. Diabetes is one of the serious complications. So, most of the market players are focused to develop an efficient, and affordable blood glucose monitor, especially, for low income population. For instance, Abbott brought a flash glucose monitoring (FGM) system to the market i.e., Freestyle Libre. In contrast to the available CGM systems, the Freestyle Libre does not require calibration.
Get Sample copy @ https://www.marketresearchfuture.com/sample_request/2030 .
Major Key Players in Global Home Healthcare Market:
Some of key the players in the market are Abbott, GE Healthcare, Becton Dickinson Company, Omron Corporation, Apple, Medtronic PLC, Koninklijke Philips N.V., LG Electronics, Fresenius SE & Co KGaA, McKesson Corporation, F. Hoffmann-La Roche AG, B. Braun Melsungen AG, 3M, A&D Company, Kinnser Software, and others.
The Americas dominate the home healthcare market owing to the presence of geriatric population, the presence of the leading players, and high healthcare expenditure. According to the WHO, world’s population aged over 60 years will nearly double from 12% to 22% by 2050, and in the United States over 20% of the total population will be aged 65 years or over by 2030.
Europe holds the second position in the home healthcare market. It is expected that the support provided by the private, and government bodies for research & development, along with a well-developed technology drives the home healthcare market in the European region.
Asia Pacific region is projected to be the fastest growing region during the forecast period. Rising treatment cost and hospital stay, and the presence of huge patient pool drive the Asia Pacific market. According to the National Heart Foundation of Australia, the cardiovascular disease is one of the most costly disease group, which costs around USD 7.7 billion a year or 10.4% of the direct healthcare expenditure. The direct healthcare expenditure for this disease includes USD 4.5 billion in hospital admissions and USD 1.65 billion in pharmaceuticals.
The Middle East and Africa hold the least share in the market is owing to the presence of poor and slow developing countries, especially, in the African region.
The Global Home Healthcare Market Consists Of Four Regions: The Americas, Europe, Asia Pacific, And The Middle East & Africa.
Home healthcare is a health care services that can be given at home for an illness or injury. With the rising demand for home healthcare, various market players are introducing various technologically advanced products to use at home such as, in 2016, Tandem Diabetes Care launched the t: slim X2 Insulin Pump.
Notably, technological advancements and increasing aging population are the key factors driving the Home Healthcare Market. In the recent years, various user-friendly new glucose monitoring devices have been approved by the FDA and European regulatory bodies such as DexCom G4 Platinum, Medtronic Diabetes Guardian Real-Time, Abbott Freestyle Libre, GMate Smart Blood Glucose Monitoring System by Philosys, Artificial pancreas system, and many others.
Other factors such as rising treatment cost and hospital stay, and rising approval from regulatory bodies, are also fueling the market growth. The treatment of chronic conditions accounts for a staggering 86% of the nation’s health care costs, suggested by the U.S. Centers for Disease Control and Prevention (CDC).
However, patient safety concerns may hinder the growth of the market over the forecast period. The home care setting may present various household-related hazards such as lead paint, toxic substances, and poor indoor air quality. There can also be a risk of spreading of nosocomial infections, medication errors, development of resistant organisms, and others
The global home healthcare market is segmented on the basis of product, services, and software.
By product, the market is segmented into testing, screening, & monitoring products, and therapeutic products. The testing, screening, & monitoring products are further segmented into blood glucose monitors, blood pressure monitors, sleep apnea monitors, pulse oximeters & heart rate monitors, cholesterol monitoring devices, Holter and event monitors, and others. The therapeutic products are further segmented into respiratory therapy equipment, insulin delivery devices, IV equipment, wound care products, dialysis equipment, others.
On the basis of services, the market is classified into skilled nursing services, rehabilitation therapy services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services.
On the basis of software, the market is classified into clinical management systems, agency software, telehealth solution, and hospice solutions.
Get Amazing Discount @ https://www.marketresearchfuture.com/check-discount/2030 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312